blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0656364

EP0656364 - Erythromycin derivatives, their process of preparation and their use as medicaments [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.08.1998
Database last updated on 16.07.2024
Most recent event   Tooltip28.08.1998No opposition filed within time limitpublished on 14.10.1998 [1998/42]
Applicant(s)For all designated states
ROUSSEL UCLAF
102 Route de Noisy
93230 Romainville / FR
[1997/43]
Former [1995/32]For all designated states
ROUSSEL UCLAF
102 Route de Noisy
F-93230 Romainville / FR
Former [1995/23]For all designated states
ROUSSEL-UCLAF
35, Boulevard des Invalides
F-75007 Paris / FR
Inventor(s)01 / Agouridas, Constantin
107, Boulevard de Strasbourg
F-94130 Nogent Sur Marne / FR
02 / Chantot, Jean-Francois
7, rue Pasteur
F-94130 Nogent Sur Marne / FR
03 / Tessot, Nicole
Hameau de la Dimeresse-Messy
F-77410 CLaye-Souilly / FR
[1995/23]
Representative(s)Vieillefosse, Jean-Claude, et al
Aventis Pharma S.A.
Département Brevets
20 avenue Raymond Aron
92160 Antony / FR
[N/P]
Former [1995/32]Vieillefosse, Jean-Claude, et al
ROUSSEL UCLAF, Département des Brevets, 111, Route de Noisy
F-93235 Romainville Cédex / FR
Former [1995/23]Tonnellier, Marie-José
ROUSSEL UCLAF Département des Brevets 111, Route de Noisy
F-93235 Romainville Cédex / FR
Application number, filing date94402759.802.12.1994
[1995/23]
Priority number, dateFR1993001450503.12.1993         Original published format: FR 9314505
[1995/23]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report 
No.:EP0656364
Date:07.06.1995
Language:FR
[1995/23]
Type: B1 Patent specification 
No.:EP0656364
Date:22.10.1997
Language:FR
[1997/43]
Search report(s)(Supplementary) European search report - dispatched on:EP30.01.1995
ClassificationIPC:C07H17/08, A61K31/70
[1995/23]
CPC:
C07H17/08 (EP,US); A61P31/04 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1995/23]
TitleGerman:Erythromycinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel[1995/23]
English:Erythromycin derivatives, their process of preparation and their use as medicaments[1995/23]
French:Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments[1995/23]
Examination procedure07.12.1995Examination requested  [1996/05]
24.01.1996Despatch of a communication from the examining division (Time limit: M06)
13.06.1996Reply to a communication from the examining division
18.02.1997Despatch of communication of intention to grant (Approval: Yes)
15.04.1997Communication of intention to grant the patent
25.07.1997Fee for grant paid
25.07.1997Fee for publishing/printing paid
Opposition(s)23.07.1998No opposition filed within time limit [1998/42]
Fees paidRenewal fee
02.01.1997Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]WO9011288  (ABBOTT LAB [US]) [Y] 1-8 * claims 1-7 *;
 [Y]EP0487411  (ROUSSEL UCLAF [FR]) [Y] 1-8 * abstract * * page 10, line 25 - page 11, line 25 *;
 [Y]  - A.B.JONES, "New Macrolide Antibiotics: Synthesis of a 14-Membered Azalide.", JOURNAL OF ORGANIC CHEMISTRY., EASTON US, (1992), vol. 57, no. 16, doi:doi:10.1021/jo00042a011, pages 4361 - 4367, XP002944402 [Y] 1-8 * the whole document *

DOI:   http://dx.doi.org/10.1021/jo00042a011
 [Y]  - D.J.HARDY ET AL., "In Vitro Activity and In Vivo Efficacy of a New Series of 9-Deoxo-12-Deoxy-9,12-Epoxyerythromycin A Derivatives.", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, WASHINGTON DC, USA., (1991), vol. 35, no. 5, pages 922 - 928, XP009013274 [Y] 1-8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.